Similar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT06643117 · TERMINATED
Trial details
- NCT number
- NCT06643117
- Sponsor
- Formycon AG
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-03
- Primary completion
- 2025-05-13
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.